An Observational Study of the Functional Capacity of Heart Failure

Status Completed

Clinical Trial Summary

This is an observational study of the functional capacity of patients with Heart failure with Reduced Ejection Fraction (HFrEF) who are admitted to the hospital for routine medical treatment.

Clinical Trial Description

This observational study will evaluate the functional capacity (ability to walk and distance walked) of patients with Heart failure with Reduced Ejection Fraction (HFrEF) in approximately 50-70 patients who present with Acute Heart Failure to approximately 5-6 hospital sites in the USA. All enrolled patients will be evaluated for their baseline functional capacity. Patients will receive standard Acute Heart Failure therapy and will be serially assessed for change in their functional capacity. ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02350114
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	N/A
Start date	November 2014
Completion date	July 2015

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02151383` - Pharmacokinetics & Safety of Serelaxin on Top of Standard of Care Therapy in Pediatric Patients With Acute Heart Failure	Phase 2
Completed	`NCT02135835` - A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure	Phase 4
Recruiting	`NCT05556044` - Empagliflozin for New On-set Heart Failure Study Regardless of Ejection Fraction	Phase 3
Recruiting	`NCT04363697` - Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)	Phase 4
Completed	`NCT02122640` - Evaluation of Acute Cardiogenic Dyspnoea With Thorax Echography and Pro-BNP in the Emergency Department	N/A
Completed	`NCT01193998` - Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department	N/A
Not yet recruiting	`NCT01211886` - Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)	N/A
Not yet recruiting	`NCT06465498` - Investigating aCute heArt failuRe Decongestion Guided by Lung UltraSonography	N/A
Recruiting	`NCT05276219` - Optimized Treatment of Pulmonary Edema or Congestion	Phase 4
Recruiting	`NCT05392764` - Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure	Phase 3
Recruiting	`NCT03157219` - Manipal Heart Failure Registry (MHFR)	N/A
Completed	`NCT06024889` - Acute Effects of Furosemide on Hemodynamics and Pulmonary Congestion in Acute Decompensated Heart Failure.	Phase 1/Phase 2
Terminated	`NCT04174794` - Investigating Reduction of aCute heArt Failure Readmission With Lung UltraSound-preliminary Trial
Recruiting	`NCT05972746` - Telemonitoring Program in the Vulnerable Phase After Hospitalization for Heart Failure	N/A
Enrolling by invitation	`NCT02258984` - Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial	N/A
Completed	`NCT02141607` - Evolution of Molecular Biomarkers in Acute Heart Failure Induced by Shock
Completed	`NCT01870778` - Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF	Phase 3
Recruiting	`NCT05986773` - Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance	Phase 4
Recruiting	`NCT04163588` - Sequential Nephron Blockade in Acute Heart Failure	Phase 3
Recruiting	`NCT04329234` - Korean Heart Failure Registry III